NSC |
Compound |
Enrichment |
Correlation |
NSC 154948 |
M-AMSA |
0.0490935610249067 |
0.46482142 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0490935610249067 |
0.28633391 |
NSC 185065 |
Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- |
0.0490935610249067 |
0.31697205 |
NSC 18805 |
.gamma.-Thujaplicine |
0.0490935610249067 |
0.38677421 |
NSC 22709 |
v-Triazolo[4,5-d]pyrimidin-7-ol |
0.0490935610249067 |
0.45079068 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.0490935610249067 |
0.61938545 |
NSC 303861 |
L-Cysteine analog |
0.0490935610249067 |
0.37644614 |
NSC 33570 |
Null |
0.0490935610249067 |
0.14997812 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0490935610249067 |
0.39447334 |
NSC 359239 |
Antibiotic X-14766A |
0.0490935610249067 |
0.19966071 |